Skip to Content

ENT 100 (Rozlytrek 100 mg)

Generic Name: entrectinib

Pill with imprint ENT 100 is Yellow, Capsule-shape and has been identified as Rozlytrek 100 mg. It is supplied by Genentech, Inc..

Rozlytrek is used in the treatment of non-small cell lung cancer; solid tumors and belongs to the drug class multikinase inhibitors. Rozlytrek 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ENT 100

Rozlytrek

Generic Name
entrectinib
Imprint
ENT 100
Strength
100 mg
Color
Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Multikinase inhibitors
CSA Schedule
Not a controlled drug
Labeler / Supplier
Genentech, Inc.
National Drug Code (NDC)
50242-0091

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.